Methylene Blue Against Vivax Malaria in Ethiopia

NCT02696928 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of ethical approval in Ethiopia

Conditions

Vivax Malaria

Interventions

DRUG: Artemeter-Lumefantrine and MB (combination therapy)
DRUG: Artemeter-Lumefantrine (combination therapy)
DRUG: Artemeter-Lumefantrine and Primaquine (combination therapy)

Sponsor

Heidelberg University

Collaborators

[object Object]
[object Object]